Although the biological basis for circulating subtype ratios remains unresolved, cross-disease comparisons indicate IFN-α predominance in SLE and relative IFN-β predominance in RA, suggesting that IFN-β bias in RA may shape therapeutic responsiveness [174,289,290]. The gene discussed is IFNA2; the disease is rheumatoid arthritis.